Showing results (231-240 of 272) with videos related to

Sort By:
Pageof 28
Journal of Experimental & Clinical Cancer Research : CR|August 8, 2021
Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targetingBeatrice Parma, Vignesh Ramesh, Paradesi Naidu Gollavilli, et al.
Cell Metabolism|September 4, 2018
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted TherapiesMaria Apicella, Elisa Giannoni, Stephany Fiore, et al.
Endocrine|September 2, 2020
Risk factors for pancreas and lung neuroendocrine neoplasms: a case-control studyLuca Giraldi, Alessia Vecchioni, Greta Carioli, et al.
The American Journal of Surgical Pathology|June 19, 2013
The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished casesEleonora Duregon, Ambrogio Fassina, Marco Volante, et al.
European Journal of Endocrinology|April 1, 2022
Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgeryMirko Parasiliti-Caprino, Fabio Bioletto, Chiara Lopez, et al.
European Journal of Endocrinology|October 23, 2019
Activity and safety of temozolomide in advanced adrenocortical carcinoma patientsDeborah Cosentini, Giuseppe Badalamenti, Salvatore Grisanti, et al.
Endocrine-Related Cancer|April 23, 2010
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II studyPaola Sperone, Anna Ferrero, Fulvia Daffara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic AlterationsMichele Simbolo, Stefano Barbi, Matteo Fassan, et al.
Carcinogenesis|August 10, 2013
An exploration of pathways involved in lung carcinoid progression using gene expression profilingDorian R A Swarts, Leander Van Neste, Mieke E R Henfling, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2013
PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapyLucia Veronica Cuorvo, Paolo Verderio, Chiara Maura Ciniselli, et al.
Pageof 28